Cell line · CVCL_0324
HuCC-T1
Cancer cell line, Homo sapiens. Intrahepatic cholangiocarcinoma. 48 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. HuCC-T1. Cell lines, record CVCL_0324. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0324
On this page
Cell line
As Cellosaurus gives it.
- Name
- HuCC-T1
- Accession
- CVCL_0324
- RRID
- RRID:CVCL_0324
- Synonyms
- HuCCT-1, HUCCT-1, HUCC-T1, HUCCT1, HuCCT1, HuccT1
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 56Y
- Category
- Cancer cell line
- Diseases
- Intrahepatic cholangiocarcinoma (NCIt C35417); Cholangiocarcinoma (ORDO Orphanet_70567)
- Derived from
- Ascites (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers48
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Targeting adaptive EGFR feedback enhances the therapeutic efficacy of RMC-6236 in cholangiocarcinoma. | Exp Hematol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Bridging the gap: a genetically validated avian chorioallantoic membrane platform for investigation of spontaneous circulating tumor cells. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An epithelial GPR35 isoform supports tumor-associated transcriptional and metabolic phenotypes. | FEBS Lett | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SMYD2 regulates lymph node metastasis derived from intrahepatic cholangiocellular carcinoma through CCR7-dependent chemotaxis. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HERV2365 upregulates FGF1 expression by sponging miR-326 to promote the progression of intrahepatic cholangiocarcinoma. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting m6A Reader YTHDF1 Enhances Antitumor Immunity and Potentiates Anti-PD-L1 Efficacy in Intrahepatic Cholangiocarcinoma. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MYC-Mediated Functional Manifestation of IDH1 Mutations in Intrahepatic Cholangiocarcinoma Confers Sensitivity to (+)-JQ1. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FXYD3 Promotes Tumor Progression by Binding With IRF7 to Regulate JAK2/STAT5 Signaling in Intrahepatic Cholangiocarcinoma. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 48
See all 48 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE HuCC-T1-FLUC | CVCL_F5UZ | Cell lines | |
| Derived from it | HuCC-T1-G10 | CVCL_QZ44 | Cell lines | |
| Derived from it | HuCC-T1-G100 | CVCL_QZ45 | Cell lines |
Cell banks6
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CLS | 300469 | CLS | |
| EDITGENE | EDC00310 | EDITGENE | |
| JCRB | JCRB0425 | JCRB | |
| KCB | KCB 202105YJ | Cellosaurus | |
| RCB | RCB1960 | RCB | |
| TKG | TKG 0389 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0324
GET https://conductscience.org/api/cell-lines/v1/CVCL_0324/papers?page=2